You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
重藥控股(000950.SZ):控股子公司成功發行8.75億元資產支持票據
格隆匯 09-24 18:04

格隆匯 9 月 24日丨重藥控股(000950.SZ)宣佈,公司於2020年3月6日召開了第七屆董事會第三十一次會議,於2020年3月23日召開了2020年第一次臨時股東大會會議,審議通過了《關於2020年度融資計劃的議案》,公司及控股子公司重慶醫藥(集團)股份有限公司2020年度擬向銀行等機構申請總額不超過130.9483億元的融資額度(包括但不限於銀行授信、超短期融資券、公司債、中期票據、應收賬款資產證券化、應收賬款資產支持票據等),其中重慶醫藥(集團)股份有限公司(含分、子公司)將申請最高額度為10億元的應收賬款資產支持票據。

重慶醫藥(集團)股份有限公司發行不超過人民幣8.75億元資產支持票據已經中國銀行間市場交易商協會註冊通過(《接受註冊通知書》中市協注[2020]ABN145號)。

重慶醫藥(集團)股份有限公司2020年度第一期資產支持票據於2020年9月24日完成發行,募集資金已於2020年9月24日到賬。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account